Mario Eandi

1.4k citations
57 papers · 1.2k · 1 hit paper · h-index 19

Impact in

Papers in

    • Antibiotics Pharmacokinetics and Efficacy 7
    • Pharmacogenetics and Drug Metabolism 4

Mario Eandi

48 papers receiving 1.1k citations

Mario Eandi's Hit Papers

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. 2020 · 244 citations
2440+2+4Years since publication50100150200

Peers

Mario Eandi
Comparison fields: 5 of 116
  • Pharmaceutical Science 136
  • Infectious Diseases 211
  • Transplantation 21
  • Pharmacology 125
  • Pharmacology 66
Replace Young‐A Heo with:
Young‐A Heo New Zealand
Adam R. Frymoyer United States
Jaymin Arvind Shah United States
Vijay K. Batra United States
Katherine F Croom New Zealand
Peter T. Daley‐Yates United Kingdom
Allan J. Coukell United States
Danial E. Baker United States
Ping Xu China
Vítor Seabra Portugal
Mario Eandi relative to Young‐A Heo New Zealand Young‐A Heo's profile →
Citations per field
00.5×2×2.8×
Young‐A Heo · 1×
Citations per year

Countries citing papers authored by Mario Eandi

Since Specialization
Citations

This map shows the geographic impact of Mario Eandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Eandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Eandi more than expected).

Fields of papers citing papers by Mario Eandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Eandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Eandi. The network helps show where Mario Eandi may publish in the future.

Co-authors

The 25 scholars most cited alongside Mario Eandi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mario Eandi Line = papers co-authored together Mario Eandi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19.
Hit paper breakdown →
2020244
2 2004147
3 200089
4 200777
5 198357
6 201043
7 200941
8 200634
9
Betahistine in the treatment of vertiginous syndromes: a meta-analysis.
200631
10 199730
11 198729
12
Absolute bioavailability of paracetamol after oral or rectal administration in healthy volunteers.
198428
13 200027
14 200225
15 201323
16
Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation.
198921
17 200421
18 201019
19 198419
20 200318

About Mario Eandi

Mario Eandi is a scholar working on Pharmacology, Oncology, Analytical Chemistry, Applied Microbiology and Biotechnology and Pharmacology, having authored 57 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Analytical Methods in Pharmaceuticals (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Analytical Chemistry and Chromatography (3 papers), Erythropoietin and Anemia Treatment (3 papers), Clinical Nutrition and Gastroenterology (3 papers), Biosimilars and Bioanalytical Methods (3 papers) and Pharmaceutical Economics and Policy (3 papers). The work is most often cited by research in Pharmaceutical Science (136 citations), Infectious Diseases (211 citations), Transplantation (21 citations), Pharmacology (125 citations) and Pharmacology (66 citations). Mario Eandi has collaborated with scholars based in Italy, Slovakia and United Kingdom. Frequent co-authors include Gian Paolo Zara, Roberto Canaparo, Elisabetta Muntoni, Loredana Serpe, Maria Rosa Gasco, Carlo Della Pepa, Ilario Viano, Lorenzo Pradelli, Roberta Cavalli and Elena Ugazio. Their work appears in journals such as Pharmacological Research, Biomedical Chromatography, British Journal of Clinical Pharmacology, Journal of Pharmaceutical and Biomedical Analysis and Chirality.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact